Mitoxantrone
-
Catalog number1885-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_name1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione
-
DescriptionAn anti-tumor antibiotic and type II topoisomerase inhibitor. It disrupts DNA synthesis and DNA repair in both healthy and cancer cells. Mitoxantrone also displays broad immunosuppressive activity inhibiting proliferation of all classes of lymphocytes and inducing apoptosis of antigen-presenting T cells.
-
CAS Number65271-80-9
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₂H₂₈N₄O₆
-
Molecular Weight444.48
-
Cell PermeableNo
-
Purity≥98%
-
SolubilitiesDMSO (~88 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA topoisomerase II inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD00242942
-
PubChem CID4212
-
SMILESC1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
-
InChiInChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2
-
InChi KeyKKZJGLLVHKMTCM-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameMitoxantrone
-
Alternative nameMitoxantrone
-